Modified CD40L‐Activated B‐Cell Proliferation Model for Validating the Suppressive Activity of CD40‐CD154 Pathway Inhibitors

Documenti analoghi

• In Vitro Evaluation of the Inhibitory Effects of Eculizumab and C1 Esterase Inhibitor on Human and Rhesus Monkey Complement
  di: Tianyi Hu, et al.
  Pubblicazione: (2025)
• Comparative Inhibitory Effects of Tacrolimus, Cyclosporine, and Rapamycin on Human Anti‐Pig Xenogeneic Mixed Lymphocyte Reactions
  di: Man Zhang, et al.
  Pubblicazione: (2024)
• In Vitro Evaluation of Basiliximab as an Induction Therapy for Xenotransplantation
  di: Hao Feng, et al.
  Pubblicazione: (2025)
• Evaluation of Complement‐Dependent Cytotoxicity Assays for Gene‐Edited Pig‐to‐Human Xenotransplantation
  di: Hao Feng, et al.
  Pubblicazione: (2025)
• Molecular incompatibility between pig CD200 and human CD200 receptor in in vitro xenogeneic immune responses
  di: Bomin Kim, et al.
  Pubblicazione: (2024)